Recent

% | $
Quotes you view appear here for quick access.

EnteroMedics Inc. Message Board

  • zanedj@ymail.com zanedj Sep 17, 2013 12:15 PM Flag

    Run up

    It will only go up from here until we hear from the FDA panel..
    If the panel recommends for approval, the stock should be trading at about $2-$2.25 area...
    At this point it's a strong buy on the run up...

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • MM's will continue to TUG on it when they can and WASH WEAK....to "gather" for a spike day

    • VBLOC CE Mark in Europe for diabetes and hypertension could be just around the corner. Abbott just got a CE mark for diabetes:
      ABBOTT PARK, Ill., Sept. 17, 2013 -- Abbott (NYSE: ABT) announced today it has received CE Marking (Conformite Europeenne) in Europe for the FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System™. The new icon-driven system provides sleek design, visual glucose trend indicators and insulin logging – all delivered in a single device to support daily diabetes management.

      According to the World Health Organization, the prevalence of diabetes is increasing in the European region. Nearly 20 percent of women and men aged 25 years and older in Europe are living with diabetes[i], which makes diabetes one of the most prevalent chronic conditions.

 
ETRM
0.1574+0.0080(+5.35%)2:20 PMEDT